Navigation Links
ASBMT Official Statement Opposing Executive Order on Immigration
Date:2/2/2017

President Donald Trump has signed an Executive Order (EO) proposing a 90-day suspension of visas and other immigration benefits to all nationals of Iran, Iraq, Syria, Sudan, Yemen, Libya and Somalia, all countries with majority Muslim populations. We hope that this order does not evolve into a permanent ban.

The American Society for Blood and Marrow Transplantation (ASBMT) opposes this EO, because it is discriminatory, contrary to our national health and security interests, and it imposes specific limits on communities that comprise our membership and are cared for by our membership.

Blood and marrow transplants are performed around the world, and the diseases treated by these transplants occur in patients regardless of their ethnicity, national origin or religious beliefs. Among other impacts, ASBMT members and their patients will be affected in the following ways:

  • Patients from these countries, and caregivers or family members of United States citizens and residents, may be unable to travel to the United States for transplant care. Potential family donors for transplant patients in the United States may be unable to travel to donate lifesaving cells.
  • Health care providers and researchers may be restricted in their ability to travel to and from affected countries to participate in medical conferences dedicated to the advancement of science and human health. These medical conferences are critical for the dissemination of scientific and clinical information and the education of health care providers and researchers in the field of transplantation and cellular therapy worldwide.

The ASBMT is a fundamentally apolitical and nonpartisan professional society. The decision to oppose this EO is based on our founding principles and our goal of advancing the scientific and professional interests of our members, and the health of our patients and their communities.

Please address questions regarding this statement to Dan Kotheimer, ASBMT Communications Manager, at 847-725-2317 or email DanKotheimer(at)asbmt(dot)org.

Read the full story at http://www.prweb.com/releases/2017/02/prweb14039001.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Former Senior FDA Official to Conduct Popular ComplianceOnline Seminar on the FDA’s Import Program
2. Knipper Announces Official Opening of New Midwest Distribution Center in the Southern Indiana – Louisville Metro Area
3. Houston Methodist Willowbrook Hospital named official health care provider for Cy-Fair Sports Association
4. 2016 BIO International Convention Sees Official Launch of BioMarketplace.com
5. Academy of Model Aeronautics Welcomes MultiGP as an official FPV Racing Special Interest Group
6. CSM Held Successful Grand Opening of New Clinical Trial Supply Facility in Malvern with Elected Officials
7. RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status
8. Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority
9. R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line.
10. Marktech West Officially Opens Facility in Semi Valley California for Production of Both Si and InGaAs Detectors
11. 12th Cold Chain GDP & Temperature Management Logistics Global Forum Officially Kicks Off in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Carilion Clinic, a national leader in opioid treatment, announced today they are partnering ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic ...
(Date:6/11/2019)... , ... June 11, 2019 , ... ... derived from human mesenchymal stem cells (MSC-EV) are able to incorporate into human ... In a test on mice, MSC-EVs also increased the cells’ ability to lodge ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
(Date:5/21/2019)... ... ... The ASGCT Clinical Trials Finder is a customizable search engine ... Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable listings anywhere in ... in the development of the ASGCT Clinical Trials Finder reviewed the relevance ...
(Date:5/21/2019)... ... 2019 , ... At their May 16 meeting, the members of the F04.43 ... the American Society for Testing and Materials International voted unanimously to approve ... next step in the company’s plan to establish its AlphaSTEM Test™ stem ...
(Date:5/16/2019)... FAYETTEVILLE, Ark. (PRWEB) , ... May 16, 2019 , ... ... PercuSense, Inc., as part of the Industry Development and Discovery Partnership that was awarded ... the development of a single integrated pod artificial pancreas (AP) system for people with ...
Breaking Biology News(10 mins):